Delivery Order SPE2DB20D7059-SPE2DB24FQJM3

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, as a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00 and running through November 2026. The contract has a ceiling value of $2,346.71 and a completion date of February 8, 2024. The award was...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $2,871.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. The contract has a ceiling value of $60,160.90 and an ultimate...
This federal contract award is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a firm fixed-price Delivery Order with a ceiling value of $13,151.67 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract, valued at $2,234.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,490.20 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 29, 2024. This award is not associated with a set-aside designation, indicating open...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $22,760.84 and a completion date of May 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 21, 2024, with a ceiling value of $2,666.94. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. This contract is not a set-aside award....
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a total ceiling value of $2,486.40. The contract has an ultimate completion date of April 26, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,038.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 21, 2023, with a completion date of November 22, 2023. The contract is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQJM3
    Delivery Order

This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract has a ceiling value of $6,528.69 and is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. There is no set-aside designation for this award.

Generated 10/14/24, 10:13 AM